臨床眼科75巻13号

2021年12月発行

連載 今月の話題

AI時代の遺伝性網膜疾患

著者： 藤波（横川）優¹²³ 藤波芳¹² 宮田裕章³

所属機関： ¹国立病院機構東京医療センター臨床研究センター視覚研究部視覚生理学研究室 ²英国ロンドン大学眼科研究所 ³慶応義塾大学医学部医療政策管理学教室

ページ範囲：P.1574 - P.1581

　遺伝性網膜疾患（IRD）は視覚障害や失明の原因となっており，個人や社会に大きな影響を与えている。遺伝型と表現型ともに多岐にわたるIRDについては「治療が皆無」とされていた時代から「治療を選択する」時代へと突入しつつあり，IRDの効率的な診断手法構築へのニーズが高まっている。本稿では，人工知能（AI）時代におけるIRDのスクリーニング・臨床遺伝学的診断について，最新の知見を含めて紹介する。

参考文献

1）藤波　芳：遺伝性網膜疾患の現状と展望．医療70：282-287，2016

2）Sohocki MM, Daiger SP, Bowne SJ et al：Prevalence of mutations causing retinitis pigmentosa and other inherited retinopathies. Hum Mutat 17：42-51, 2001

3）Liew G, Michaelides M, Bunce C：A comparison of the causes of blindness certifications in England and Wales in working age adults（16-64 years）, 1999-2000 with 2009-2010. BMJ Open. doi：10.1136/bmjopen-2013-004015, 2014.

4）厚生労働科学研究費補助金難治性疾患政策研究事業網膜脈絡膜・視神経萎縮症に関する調査研究班　網膜色素変性診療ガイドライン作成ワーキンググループ：網膜色素変性診療ガイドライン．日眼会誌120：846-861，2016

5）Morizane, Y, Morimoto N, Fujiwara A et al：Incidence and causes of visual impairment in Japan：the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol 63：26-33, 2019

6）Roberts CB, Hiratsuka Y, Yamada M et al：Economic cost of visual impairment in Japan. Arch Ophthalmol 128：766-771, 2010

7）Galvin O, Chi G, Brady L et al：The impact of inherited retinal diseases in the Republic of Ireland（ROI）and the United Kingdom（UK）from a cost-of-illness perspective. Clin Ophthalmol 14：707-719, 2020

8）Takeuchi M, Seto T, Hashimoto M et al：Performance of a deep learning-based identification system for esophageal cancer from CT images. Esophagus 18：612-620, 2021

9）Abràmoff MD, Lou Y, Erginay A et al：Improved automated detection of diabetic retinopathy on a publicly available dataset through integration of deep learning. Invest Ophthalmol Vis Sci 57：5200-5206, 2016

10）Abràmoff MD, Lavin PT, Birch M et al：Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices. NPJ Digit Med. doi：10.1038/s41746-018-0040-6, 2018

11）Asaoka R, Murata H, Iwase A et al：Detecting preperimetric glaucoma with standard automated perimetry using a deep learning classifier. Ophthalmology 123：1974-1980, 2016

12）Li JO, Liu H, Ting DSJ et al：Digital technology, tele-medicine and artificial intelligence in ophthalmology：A global perspective. Prog Retin Eye Res. doi：10.1016-j.preteyeres.2020.100900, 2021

13）Kawaguchi A, Sharafeldin N, Sundaram A et al：Tele-ophthalmology for age-related macular degeneration and diabetic retinopathy screening：a systematic review and meta-analysis. Telemed J E Health 24：301-308, 2018

14）Takahashi H, Tampo H, Arai Y et al：Applying artificial intelligence to disease staging：Deep learning for improved staging of diabetic retinopathy. PLoS One. doi：10.1371/journal.pone.0179790, 2017

15）Yousefi S, Yousefi E, Takahashi H et al：Keratoconus severity identification using unsupervised machine learning. PLoS One. doi：10.1371/journal.pone.0205998, 2018

16）藤波　芳・藤波　優・Yang Lizhu・他：遺伝性網膜疾患に対する遺伝子治療．臨眼74：1472-1483，2020

17）Georgiou M, Fujinami K, Michaelides M：Inherited retinal diseases：therapeutics, clinical trials and end points-a review. Clin Exp Ophthalmol 49：270-288, 2021

18）Russell S, Bennett J, Wellman JA et al：Efficacy and safety of voretigene neparvovec（AAV2-hRPE65v2）in patients with RPE65-mediated inherited retinal dystrophy：a randomised, controlled, open-label, phase 3 trial. Lancet 390：849-860, 2017

19）Maguire AM, Russell S, Wellman JA et al：Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy：results of phase 1 and 3 trials. Ophthalmology 126：1273-1285, 2019

20）Smith J, Ward D, Michaelides M et al：New and emerging technologies for the treatment of inherited retinal diseases：a horizon scanning review. Eye（Lond）29：1131-1140, 2015

21）Scholl HPN, Strauss RW, Singh MS et al：Emerging therapies for inherited retinal degeneration. Sci Transl Med. doi：10.1126/scitranslmed.aaf2838, 2016

22）藤波　芳：ゲノム情報と国内・国際ネットワーク．あたらしい眼科34：987-993，2017

23）藤波　芳・藤波（横川）優・Lizhu Yang・他：黄斑ジストロフィの分子病態．眼科60：309-321，2018

24）Georgiou M, Fujinami K, Michaelides M：Retinal imaging in inherited retinal diseases. Ann Eye Sci. doi：10.21037/aes-20-81, 2020

25）Fujinami K, Yang L, Joo K et al：Clinical and genetic characteristics of east asian patients with occult macular dystrophy（Miyake disease）：East Asia occult macular dystrophy studies report number 1. Ophthalmology 126：1432-1444, 2019

26）Yang L, Fujinami K, Ueno S et al：Genetic spectrum of EYS-associated retinal disease in a large Japanese cohort：identification of disease-associated variants with relatively high allele frequency. Sci Rep 10：5497, 2020

27）Fujinami-Yokokawa Y, Ninomiya H, Liu X et al：Prediction of causative genes in inherited retinal disorder from fundus photography and autofluorescence imaging using deep learning techniques. Br J Ophthalmol 105：1272-1279, 2021

28）角田和繁：網脈絡膜ジストロフィの遺伝学的病態解明および治療に向けた症例データバンクの構築．日眼会誌124：247-284，2020

29）Oishi M, Oishi A, Gotoh N et al：Comprehensive molecular diagnosis of a large cohort of Japanese retinitis pigmentosa and Usher syndrome patients by next-generation sequencing. Invest Ophthalmol Vis Sci 55：7369-7375, 2014

30）Koyanagi Y, Akiyama M, Nishiguchi KM et al：Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients. J Med Genet 56：662-670, 2019

31）Hosono K, Nishina S, Yokoi T et al：Molecular diagnosis of 34 Japanese families with leber congenital amaurosis using targeted next generation sequencing. Sci Rep 8：8279, 2018

32）Pontikos N, Murphy C, Moghul I et al：Phenogenon：gene to phenotype associations for rare genetic diseases. PLoS One. doi：10.1371/journal.pone.0230587, 2020

33）Fujinami-Yokokawa Y, Pontikos N, Yang L et al：Prediction of causative genes in inherited retinal disorders from spectral-domain optical coherence tomography utilizing deep learning techniques. J Ophthalmol. doi：10.1155/2019/1691064, 2019